Expert Highlights Evolution of Biosimilars in Oncology
Pharma & biotech2018-06-29
33 Views
Michael Savin, MD, discusses the emergence of biosimilars in oncology, and why there are still obstacles with incorporating them into clinical practice.
Source: OncLive
The news, reports, views and opinions of authors (or source) expressed are their own and do not necessarily represent the views of CRWE World.
How Animated Explainer Videos Communicate Ideas Visually
Lightning Safety Planning for Homeowners and Families
